DHEA Treatment for Sjogren's Syndrome

NCT00001598 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

NIH

Sponsor class

Conditions

Lacrimal Apparatus Disease
Salivary Gland Disease
Sjogren's Syndrome
Xerostomia

Interventions

DRUG: Dehydroepiandrosterone

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)